BINEX Co., Ltd. (KOSDAQ:053030)
7,320.00
-430.00 (-5.55%)
Jun 30, 2026, 3:30 PM KST
BINEX Market Cap
BINEX has a market cap or net worth of 233.12 billion as of June 30, 2026. Its market cap has decreased by -58.34% in one year.
Market Cap
233.12B
Enterprise Value
316.72B
Revenue
164.00B
Ranking
n/a
PE Ratio
n/a
Stock Price
7,320.00
Market Cap Chart
Since March 1, 2002, BINEX's market cap has increased from 25.29B to 233.12B, an increase of 821.95%. That is a compound annual growth rate of 9.55%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 30, 2026 | 233.12B | -51.13% |
| Dec 30, 2025 | 477.08B | -18.32% |
| Dec 30, 2024 | 584.09B | 111.03% |
| Dec 28, 2023 | 276.77B | -22.51% |
| Dec 29, 2022 | 357.18B | -24.01% |
| Dec 30, 2021 | 470.05B | -43.25% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| MEDIPOST | 370.14B |
| Proteina | 345.40B |
| SillaJen | 341.53B |
| Genomictree | 280.03B |
| GC Cell | 238.93B |
| HLB Therapeutics | 211.97B |
| EASY BIO,Inc. | 207.42B |
| Anterogen.Co.,Ltd. | 207.13B |